Free Trial
ASX:BDA

Bod Australia (BDA) Stock Price, News & Analysis

About Bod Australia Stock (ASX:BDA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
75,095 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bod Australia Limited operates as a cannabis centric healthcare company in Australia, the United Kingdom, and internationally. The company operates through three segments: Medical, OTC CBD/Hemp, and OTC Herbals. It offers medicinal cannabis, cannabidiol (CBD), and hemp healthcare products. The company has a collaboration agreement with Drug Science UK to assess the efficacy of its medicinal cannabis, MediCabilis in managing symptoms associated with the long term impact of SARS-CoV-2. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.

Receive BDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bod Australia and its competitors with MarketBeat's FREE daily newsletter.

BDA Stock News Headlines

Post-Election Market Insights: Stocks to Watch in 2025
The dust has settled on the 2024 elections, and markets are already responding to the new political landscape. Now is the perfect time to adjust your strategy and take advantage of fresh opportunities emerging from these developments. We’re excited to share our updated report, “Post-Election Investment Gems: Top Stocks Set to Thrive in 2025.” This guide is designed to equip you with timely insights and actionable strategies in today’s evolving market.
UK logs another SEVENTY-SEVEN monkeypox cases
Will Bod Australia (ASX:BOD) Spend Its Cash Wisely?
BOD Australia Ltd (BDA)
See More Headlines

BDA Stock Analysis - Frequently Asked Questions

Bod Australia Limited (ASX:BDA) issued its quarterly earnings results on Thursday, February, 28th. The company reported ($0.05) earnings per share (EPS) for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bod Australia investors own include Queensland Pacific Metals (QPM), Argent BioPharma (MXC), Medlab Clinical (MDC), Lynas Rare Earths (LYC), iSignthis (ISX), Imugene (IMU) and Eclipx Group (ECX).

Company Calendar

Last Earnings
2/28/2019
Today
1/22/2025

Industry, Sector and Symbol

Industry
Household & Personal Products
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.42 million
Book Value
A$0.08 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (ASX:BDA) was last updated on 1/23/2025 by MarketBeat.com Staff
From Our Partners